SELLAS Life Sciences Group, Inc. — Director's Dealing 2016

Jul 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2016-07-14

Reporting Person: Ashton William (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-14	Stock Option (right to buy)	$0.41	A	100000	Acquired	2026-07-14	Common Stock (100000)	Direct

Footnotes

F1: Granted pursuant to the Issuer's 2016 Incentive Plan.

F2: This stock option will vest and become exercisable in equal, quarterly installments over one year, beginning three months from July 14, 2016, such that the option will be fully exercisable as of July 14, 2017.